[ Pobierz całość w formacie PDF ]
use for immunogenicity studies assuming all reason- J Immunol 175:3084 3091.
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 1, JANUARY 2011 DOI 10.1002/jps
VACCINE FORMULATIONS DURING PRECLINICAL RESEARCH 37
17. Wright JF. 2008. Manufacturing and characterizing AAV- 19. FDA. 1997. Guidance for Industry for the Evaluation of Com-
based vectors for use in clinical studies. Gene Ther 15:840 bination Vaccines for Preventable Diseases: Production, Test-
848. ing and Clinical Studies. In Research CfBEa, editor. U.S.
18. Przybylowski M, Bartido S, Borquez-Ojeda O, Sadelain M, Department of Health and Human Services.
Riviere I. 2007. Production of clinical-grade plasmid DNA for 20. Blatteis Clark M, Sehic E, Li S. 2000. Pyrogen sensing and
human Phase I clinical trials and large animal clinical studies. signaling: Old views and new concepts. Clin Infect Dis 31:
Vaccine 25:5013 5024. S168 S177.
DOI 10.1002/jps JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 1, JANUARY 2011
[ Pobierz całość w formacie PDF ]
© 2009 Silni rzÄ…dzÄ…, sÅ‚abych rzuca siÄ™ na pożarcie, ci poÅ›redni gdzieÅ› tam przemykajÄ… niezauważeni jak pierd-cichacz. - Ceske - Sjezdovky .cz. Design downloaded from free website templates